Janssen Expands Biomanufacturing Capabilities in Ireland

Janssen Sciences to invest over $350 million at its site in Ringaskiddy, County Cork, Ireland.

Janssen Sciences Ireland UC, part of Johnson & Johnson (J&J), has a 400,000-square-meter biopharmaceutical supply-chain facility in Ringaskiddy, County Cork, Ireland that it has operated since 2005. To meet growing demand, the manufacturing space at the site will be expanded by an additional 19,100 square-meters, according to the company.

Janssen will invest over $354 million on a new manufacturing building and to expand its existing warehouse, laboratory, and administration buildings, as well as to upgrade other site infrastructure, including utilities, car parking, underground services, internal roads, yards, and pipe racks. The on-site wastewater treatment plant will also be expanded to accommodate the greater production volumes resulting from the investment.

This expansion will increase Janssen’s global manufacturing capacity of biologic medicines, which is in keeping with our Credo commitment to provide the highest quality products to patients,” said Remo Colarusso, Vice President, Manufacturing and Technical Operations. “Our Ringaskiddy site is an important part of Janssen’s global manufacturing network and this expansion will allow us to grow in a location that offers an advanced infrastructure, a high-performance culture and top-level talent.” 

Added Kyran Johnson, General Manager, Janssen Supply Chain Ireland: “This expansion project is a significant vote of confidence in our team and one which will increase our manufacturing footprint very significantly, allowing us to continue to meet critical patient needs in the areas of Multiple Myeloma, Rheumatoid Arthritis and Crohn’s Disease.” 

Construction is commencing in October 2017 and is anticipated to take about two years. Up to 450 people will be employed during the construction phase, with 200 permanent employees hired on once the project is completed.

“I warmly welcome Janssen's ongoing commitment to Ireland with this expansion of its manufacturing facility in Ringaskiddy,” said Frances Fitzgerald, An Tánaiste and Minister for Business, Enterprise and Innovation.  “The pharma industry makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports, and is one of our fastest growing sectors. This expansion announced today by Janssen is a strong commitment to our country and I wish them continued success.”

 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.